- Home
- Companies
- us virgin islands
- tumor markers
Refine by
Tumor Markers Suppliers Serving Us Virgin Islands
48 companies found
based inShenzhen, CHINA
Genrui Biotech Inc. is one of the leading Chinese IVD medical device companies specializing in developing, manufacturing and marketing IVD(in vitro diagnostics) instruments and reagents and other IVD solutions. Established in 2004, Genrui has made ...
FA50 is a simple, innovative and accurate POCT Immunofluorescence analyzer that has obtained CE, FDA and NGSP certificates. Combined with magnetic card auto-calibration, it can test different sample types including whole blood, serum and plasma. ...
based inBrea, CALIFORNIA (USA)
We are pleased to announce the exclusive commercialization and sale of KinesisDx product lines to Krishgen Biosystems, India for worldwide usage effective July 11, 2019. This is in line with our philosophy to partner with forward looking companies ...
based inShanghai, CHINA
Tellgen Corporation was established in 2003 at the Medicine Valley in Shanghai, also known as the Silicon Valley of China, which is the first to develop reagents based on Luminex Platforms. Went public in 2017 in Shenzhen and grew to 1000 employees. ...
The TESMI F4000 System is an autoanalyzer based on flow cytometry. This multiplex system is able to test up to 100 analytes in one sample with a minimum sample size. It can do nucleic acid assays, receptor-ligand assays, immunoassays and enzymatic ...
based inAllentown, PENNSYLVANIA (USA)
Arista Biologicals is a leading manufacturer and supplier of rapid diagnostic reagents, components and related equipment for membrane-based assays. Reagents include colloidal gold conjugates, antigens, and antibodies used for assays such as ...
based inPoway, CALIFORNIA (USA)
Alfa Scientific Designs, Inc. is a California-licensed, cGMP compliant, and ISO 13485 registered manufacturer of in-vitro diagnostic devices. Founded in 1996, ALFA is a leader in the industry in developing and manufacturing high quality rapid ...
based inSouth San Francisco, CALIFORNIA (USA)
BioCheck, located in the San Francisco Bay Area, was founded in April 1997, to develop and manufacture high-quality enzyme immunoassay test kits for the worldwide biomedical, pharmaceutical and scientific research markets. The founders have brought ...
BioCheck provides a variety of services including: Custom Immunoassay Development, ELISA, Ultrasensitive Immunoassays using Simoa (single molecule array) Technology, Antibody Purification and Conjugation, Contract Manufacturing and ...
based inKiel, GERMANY
Demeditec Diagnostics is a supplier for diagnostic testkits to be used in the clinical laboratory and in research labs as well. The technology of our testkits covers radioactive (RIAs) and non-radioactive (ELISA, rapid tests) origin. Most of our ...
based inWest Lafayette, INDIANA (USA)
Tymora Analytical Operations provides diagnostic development and exosome proteomics contract services and products for improved cancer research. Tymora’s primary goal is to enable the shift from tissue to liquid biopsy. Our new technologies allow ...
based inBallina, IRELAND
Technopath Clinical Diagnostics is now part of LGC Clinical Diagnostics. The announcement was made on February 1st 2021. LGC Diagnostics is a leading in vitro diagnostic (IVD) manufacturer of clinical diagnostic quality solutions and test components ...
Multichem IA contains 83 analytes including fertility and thyroid hormones, steroid hormones, cardiac markers, anaemia markers, therapeutic drugs, adrenal markers and bone metabolism ...
based inPoway, CALIFORNIA (USA)
Diazyme uses its proprietary enzyme technologies to develop diagnostic reagents which can be used on most automated chemistry analyzers in user-friendly formats. Diazyme's products include test kits for diagnosis of cardiovascular disease, liver ...
based inGolestan Town, IRAN
Pishtaz Teb Zaman Diagnostics, started its research, development, and marketing activities in 1998, and rapidly grew to be an international brand specialized in 'In-Vitro Diagnostics Medical Devices and Clinical research'. Our range of products are ...
Alpha-Feto Protein (AFP) is a 70,000 kDa glycoprotein molecule which is closely related to human albumin both genetically and structurally. AFP is produced initially by the fetal yolk sac in small quantities and then in large quantities by the fetal ...
based inHouston, TEXAS (USA)
Healgen Scientific, a wholly owned subsidiary of Zhejiang Orient Gene Biotech Co.,Ltd, develops, manufactures and commercializes in-vitro diagnostic test systems worldwide. Our product portfolio spans multiple testing categories and analytes to meet ...
The Alpha-Fetoprotein (AFP) Rapid Test is a rapid chromatographic immunoassay for the qualitative detection of AFP in whole blood, serum or plasma to aid in the diagnosis of Hepatocellular Carcinoma or fetal open neural tube defects. ...
based inCarlsbad, CALIFORNIA (USA)
Coretests products has been certified by ISO 9001, ISO 13485, CE, and FDA. Our team has develop numerous products, ranging from proteins, rapid tests, to PCR and POCT products. The hundreds of products fall under five categories, Fertility, Drug of ...
INTENDED USE: The Fecal Occult Blood Test Device is a qualitative test that detects human hemoglobin in human fecal specimens. The test is a visual one step, in-vitro assay. It is intended for professional use to help diagnose gastrointestinal ...
based inBerlin, GERMANY
At SOMATEX, we design high quality single-use medical devices to facilitate diagnoses and therapies. That is how we contribute to making everyday life easier in the medical sector for users and patients. Our products are high quality, well thought ...
based inBoca Raton, FLORIDA (USA)
Clarity Diagnostics, LLC is a manufacturer and market leader of rapid diagnostic tests, diagnostic equipment, and over-the-counter rapid diagnostic tests that are targeted toward the Continuum of Care, Alternate Care, Acute Care, Laboratory, and OTC ...
based inÜmraniye, TURKEY
Vitrosens Biotechnology is a high-tech company in Turkey founded for the development, manufacture, and delivery of in vitro diagnostic devices (IVD) to the world. Vitrosens Biotechnology headquartered in Turkey, by a group of entrepreneurs with a ...
The test kit qualitatively detects alpha fetoprotein (AFP) in human serum, plasma and whole blood ...
based inZhengzhou, CHINA
Since 2014, DiaSino Laboratories specialized in design, development, manufacture and worldwide distribution of Immunodiagnostic reagents, including three platforms: Porrima fully automatic chemiluminescence immunoassay, Infinosis fluorescent ...
based inSanta Clara, CALIFORNIA (USA)
LumiQuick Diagnostics Inc., located in the heart of Silicon Valley, California, USA, develops, manufactures and markets high quality point of care tests and other immunoassay kits for the world-wide In vitro diagnostic market. Through years of ...
LumiQuick QuickProfile Cancer Marker Tests are In vitro immunochromatography based one-step assays that include Fecal Occult Blood, (FOB), Alpha Fetoprotein (AFP), Prostate Specific Antigen (PSA) and Carcinoembryonic Antigen ...
based inMalvern, PENNSYLVANIA (USA)
A proven pioneer and partner to the diagnostics industry. Fujirebio is an R&D-driven company constantly developing new technologies and unique biomarkers with high clinical value. Our group mission is to create new value in healthcare and thereby ...
CanChek Tumor Marker Control Serum is intended for use as an assayed quality control serum to monitor the accuracy of laboratory testing for neuron specific enolase (NSE), S100B protein and squamous cell carcinoma ...
based inNew York, NEW YORK (USA)
Acuamark Diagnostics develops technology which allows for highly accurate screening of blood to detect cancer markers at the early cancer stages, before the cancer becomes untreatable. Backed by a highly experienced team of scientific and business ...
The vast majority of cancer cases are detected at stage III or beyond, resulting in poor cancer survival of ~50% in the aggregate. Cancer cases are forecasted to reach 25M per year over the next two decades, causing deaths to rise to 13M per ...